EichorEICHOR
Location: Mobile Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Mobile

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · USA Mitchell Cancer Institute ( Site 0014) · Merck Sharp & Dohme LLC · NCT06136559
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Infirmary Cancer Care ( Site 0001) · Merck Sharp & Dohme LLC · NCT06393374
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · USA Health Strada Patient Care Center · National Cancer Institute (NCI) · NCT06172296
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · AMR Mobile · Kallyope Inc. · NCT07674654
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Mobile Infirmary Medical Center · NRG Oncology · NCT05624996
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
NA · University of South Alabama Health · Tela Bio Inc · NCT07070115
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · Cardiology Associates · Duke University · NCT07232069
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT06368817
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Mobile Heart Specialists PC · Amgen · NCT07037433
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · USA Health University Hospitals ( Site 0020) · Merck Sharp & Dohme LLC · NCT07044297
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Infirmary Cancer Care · Eli Lilly and Company · NCT06890598
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · East View Medical Research · Janssen Research & Development, LLC · NCT07499232
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT04322318
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Mobile Infirmary Medical Center · NRG Oncology · NCT05174169
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · AMR Clinical · Eli Lilly and Company · NCT07353931
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Infirmary Cancer Care ( Site 0157) · Merck Sharp & Dohme LLC · NCT06890884
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0487 · Bristol-Myers Squibb · NCT06561386
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · USA Health Children's and Women's Hospital · Pfizer · NCT06866405
Caris Biorepository Research Protocol
Phase N/A · University of South Alabama · Caris Science, Inc. · NCT01499394
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · USA Health Strada Patient Care Center · Children's Oncology Group · NCT04293562
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Infirmary Cancer Care · Boehringer Ingelheim · NCT07472517
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Phase 3 · University of South Alabama (USA) Physicians Group · Takeda · NCT05442567
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Mobile Heart Specialists · Novartis Pharmaceuticals · NCT07517263
Project: Every Child for Younger Patients With Cancer
Phase N/A · USA Health Strada Patient Care Center · Children's Oncology Group · NCT02402244
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · University of South Alabama Mitchell Cancer Institute · NRG Oncology · NCT04852887
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1041 · Anthos Therapeutics, Inc. · NCT05712200
Look up another city
Look up another condition